Profit Investment Management, LLC Invitae Corp Transaction History

Profit Investment Management, LLC

$178 Million
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$1.71 - $3.61 $9,312 - $19,660	-5,446 Reduced 12.43%	38,362 $0
Q3 2022 Oct 13, 2022	SELL	$1.9 - $8.63 $244,891 - $1.11 Million	-128,890 Reduced 74.63%	43,808 $108,000
Q2 2022 Jul 11, 2022	SELL	$2.13 - $9.01 $173,699 - $734,756	-81,549 Reduced 32.07%	172,698 $420,000
Q1 2022 Apr 20, 2022	BUY	$6.28 - $15.59 $324,085 - $804,537	51,606 Added 25.47%	254,247 $2.03 Million
Q4 2021 Jan 19, 2022	BUY	$14.7 - $28.67 $227,511 - $443,725	15,477 Added 8.27%	202,641 $3.1 Million

Q3 2021 Oct 08, 2021	BUY	$24.31 - $33.6 $1.23 Million - $1.7 Million	50,698 Added 37.15%	187,164 $5.32 Million
Q1 2021 Apr 14, 2021	SELL	$33.06 - $56.93 $340,749 - $586,777	-10,307 Reduced 7.02%	136,466 $5.22 Million
Q4 2020 Jan 20, 2021	BUY	$39.09 - $57.4 $12,704 - $18,655	325 Added 0.22%	146,773 $6.14 Million
Q3 2020 Nov 09, 2020	SELL	$28.43 - $44.67 $428,553 - $673,355	-15,074 Reduced 9.33%	146,448 $6.35 Million
Q2 2020 Jul 16, 2020	SELL	$11.71 - $30.29 $216,834 - $560,879	-18,517 Reduced 10.28%	161,522 $4.89 Million
Q1 2020 Apr 23, 2020	SELL	$7.64 - $27.5 $31,537 - $113,520	-4,128 Reduced 2.24%	180,039 $2.46 Million
Q4 2019 Jan 15, 2020	BUY	$15.02 - $20.57 $199,750 - $273,560	13,299 Added 7.78%	184,167 $2.97 Million
Q3 2019 Oct 17, 2019	BUY	$18.85 - $27.5 $857,147 - $1.25 Million	45,472 Added 36.26%	170,868 $3.29 Million
Q2 2019 Jul 16, 2019	BUY	$17.37 - $26.27 $592,716 - $896,411	34,123 Added 37.39%	125,396 $2.95 Million
Q1 2019 Apr 12, 2019	BUY	$10.65 - $25.75 $972,057 - $2.35 Million	91,273 New	91,273 $2.14 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profit Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profit Investment Management, LLC with notifications on news.

Account